| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.07 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.24 | 0.07 |